A prophylactic or therapeutic agent for at least one cancer selected from a group consisting of pancreatic cancer, lung cancer, large bowel cancer, bile duct cancer and liver cancer, a prophylactic or therapeutic agent for combination medicine combined with the drug, a combination medicine comprising the drug, and a method for screening or preventing cancer prevention or therapeutic agent

摘要

Pancreatic cancerLung cancerColon cancerA prophylactic or therapeutic agent of at least one cancer selected from the group consisting of bile duct cancer and liver cancerCombination or preventive agent of the cancer for combination medicine combined with the agentCombination medicine containing the drugAndPancreatic cancerLung cancerColon cancerProblem to be solved: to provide a method for screening prophylactic or therapeutic agents of at least one cancer selected from the group consisting of bile duct cancer and liver cancer.A preventive or therapeutic agent of at least one type of cancer selected from the group consisting of pancreatic cancer, lung cancer, colon cancer, bile duct cancer and liver cancer, a substance that reduces the expression of the mex3b gene or the mx3b protein, or the inhibitor of the mex3b protein.Diagram